Hyper-IgE syndrome 6, autosomal dominant, with recurrent infections: genes and variants
Explore variant evidence for Hyper-IgE syndrome 6, autosomal dominant, with recurrent infections across 2 analyzed proteins (STAT6, STAT3). Linked ClinVar records include 6 pathogenic or likely pathogenic variants, 0 variants of uncertain significance and 0 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Hyper-IgE syndrome 6, autosomal dominant, with recurrent infections
STAT6: Signal transducer and activator of transcription 6
It mediates IL-4 and IL-13 signaling that drives type 2 immunity, IgE responses, and alternative macrophage activation. Gain-of-function germline variants can cause severe early-onset allergic disease and immune dysregulation, while pathway inhibition is therapeutically useful in atopic disorders.
6 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in STAT6 have source records linked to Hyper-IgE syndrome 6, autosomal dominant, with recurrent infections. Association strength is not clinical gene validity.
STAT3: Signal transducer and activator of transcription 3
It translates cytokine and growth-factor signals into transcriptional programs governing immune regulation, survival, proliferation, and tissue repair. Dominant-negative variants cause hyper-IgE syndrome, while activating germline variants cause early autoimmunity and lymphoproliferation and somatic activation contributes to cancer.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in STAT3 have source records linked to Hyper-IgE syndrome 6, autosomal dominant, with recurrent infections. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Hyper-IgE syndrome 6, autosomal dominant, with recurrent infections
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| STAT6 D419H | 419 | Pathogenic / likely pathogenic (★) | |
| STAT6 D419G | 419 | Pathogenic / likely pathogenic | |
| STAT6 D419Y | 419 | Pathogenic / likely pathogenic | |
| STAT6 E372K | 372 | Pathogenic / likely pathogenic | |
| STAT6 E382Q | 382 | Pathogenic / likely pathogenic | |
| STAT6 D519H | 519 | SH2 | Pathogenic / likely pathogenic |
Diseases related to Hyper-IgE syndrome 6, autosomal dominant, with recurrent infections
- Hyper-IgE recurrent infection syndrome, also linked to STAT3
- STAT3 gain of function, also linked to STAT3
- STAT3-related early-onset multisystem autoimmune disease, also linked to STAT3
- Inherited Immunodeficiency Diseases, also linked to STAT3
- Crohn disease, also linked to STAT3
Frequently asked questions
Which genes have records linked to Hyper-IgE syndrome 6, autosomal dominant, with recurrent infections?
This view contains 2 analyzed proteins: STAT6, STAT3. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 6 pathogenic or likely pathogenic variants, 0 variants of uncertain significance and 0 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 12 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center